Preparing for Ebola: What U.S. Hospitals Can Learn From Emory Healthcare and Nebraska Medical Center

Date:Tuesday, October 14, 2014

Time:2:00 – 3:00 PM (Eastern Time)

Presenter(s)

Overview

The Ebola outbreak in West Africa has increased the possibility of patients traveling from the impacted countries to U.S. hospitals. A few patients with Ebola virus disease have been medically evacuated to receive care in U.S. hospitals. Recently, the first case of Ebola virus disease was diagnosed in the United States in a person who traveled to Dallas, Texas from West Africa; this patient passed away on October 8, 2014. CDC and our partners are taking precautions to prevent the spread of Ebola within the United States. During this COCA Call, the presenters will focus on healthcare systems preparedness, and participants will learn how Emory Healthcare and Nebraska Medical Center prepared for patients with Ebola and the lessons learned.

Please note: the focus of this call will be healthcare systems preparedness, not clinical management of the patients with Ebola.

Call Materials

• Slides: View Now
• Audio: Listen Now
• Transcript: Read Now

Additional Resources

• CDC Ebola Virus Disease: Information for Healthcare Workers
• University of Nebraska Medical Center Donning Resource
• University of Nebraska Medical Center Doffing Resource

Call Format

• Audio conference call on 10/14/14: 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 10/14/14

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 0.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 0.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.0 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-14-166-L04-P and enduring 0387-0000-14-166-H04-P course category.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 0.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.